Addiction Treatment - Articles - Page 6

Clinical Update

Benzodiazepines: The Basics and Beyond

October 31, 2023

Audrey Abelleira, PharmD, BCPP. Clinical pharmacist practitioner, VA Connecticut Healthcare System; clinical instructor, Yale School of Medicine, New Haven, CT.

Dr. Abelleira has no financial relationships with companies related to this material.

Benzodiazepines vary widely in their pharmacologic properties such as half-life, lipophilicity, and medication interactions. Here, we review the essential pharmacology of the prominent benzodiazepine agents and draw clinical correlates to how these properties translate to patient care.

CME Post-Test, Revisiting Opioid Use Disorder, CATR, Jul/Aug/Sept 2023

May 29, 2023

Learning Objectives, Revisiting Opioid Use Disorder, CATR, Jul/Aug/Sept 2023

May 29, 2023

After reading these articles, you should be able to…

Research Update

Intravenous Buprenorphine Microinduction

May 29, 2023

Noah Capurso, MD and Marissa Bayerl, APRN

Marissa Bayerl, APRN, and Noah Capurso, MD, MHS. Ms. Bayerl and Dr. Capurso have no financial relationships with companies related to this material.

Buprenorphine microinduction can be a useful method of starting BUP induction, however it is not always feasible, particularly in the hospital setting. Here, we discuss the development of an intravenous microinduction protocol that could provide an alternative to the usual sublingual and transdermal routes of administration.

Clinical Update

What Psychiatrists Need to Know About Intravenous Drug Use and Endocarditis

May 29, 2023

Kenechukwu Mezue, MD, MSc and Bernardo Lombo, MD, FACC

Kenechukwu Mezue, MD, MSc. Clinical Fellow in Cardiovascular Medicine, Yale School of Medicine, New Haven, CT.

Bernardo Lombo, MD, FACC. Assistant Professor of Cardiology, Yale School of Medicine, New Haven, CT.

Dr. Mezue and Dr. Lombo have no financial relationships with companies related to this material.

Infective endocarditis (IE) is a dangerous and potentially life-threatening complication of intravenous drug use. This article explores the pathogenesis of IE, key symptoms to recognize, and the crucial steps to take if an infection is suspected.

Expert Q&A

Starting Medication for Opioid Use Disorder

May 29, 2023

Gretchen Hermes, MD, PhD

Gretchen Hermes, MD, PhD.

Medical Director, APT Foundation; Assistant Professor, Department of Psychiatry, Yale School of Medicine, New Haven, CT.

Dr. Hermes has no financial relationships with companies related to this material.

Dr. Hermes discusses the intricacies of medications for opioid use disorder by outlining the advantages, disadvantages, and side effect profile of each. She will help you choose the best treatment approach for your patients with opioid use disorder by providing a review of relevant literature and gives you language to use in the clinic.

Expert Q&A

The State of Opioids on the Street

May 29, 2023

Daniel Ciccarone, MD, MPH

Daniel Ciccarone, MD, MPH.

Justine Miner Professor of Addiction Medicine at the University of California San Francisco.

Dr. Ciccarone is a member of the scientific advisory board for Celero Systems. Relevant financial relationships listed for the author have been mitigated.

Dr. Ciccarone sheds light on the current chaotic and perilous situation surrounding illicit opioids found on the streets.

Clinical Update

Fentanyl Testing: An Emerging Harm Reduction Strategy

May 29, 2023

Noah Capurso, MD and Alyssa Falleni, PharmD

Alyssa Falleni, PharmD. CT Health Education and Research in SUD and Related Harms (CHERISH) Fellow; VA Connecticut Healthcare System, Orange, CT.

Noah Capurso, MD, MHS. Assistant Professor of Psychiatry, Yale University, New Haven, CT; Editor-in-Chief of The Carlat Addiction Treatment Report.

Dr. Falleni and Dr. Capurso have no financial relationships with companies related to this material.

Discover the lifesaving potential of fentanyl test strips (FTS). As fentanyl infiltrates illicit drug markets, FTS offer an essential harm reduction strategy. We’ll explore the technology behind FTS, how to obtain and use them, discuss their legality, and examine their role in preventing opioid overdose deaths.